
ChemT Biotechnology is an AI-driven company focused on transforming the biologics manufacturing industry, including the production of antibodies, proteins, and cell therapies. Their proprietary AI-driven cellular drug discovery platform optimizes biologics production, enhancing yield and efficacy. Their flagship product, Chemplify™, significantly boosts T cell yield and quality, setting a new industry benchmark for immunotherapies. With a strong team of experts from leading institutions and companies, ChemT aims to replace traditional components in biologics manufacturing with innovative small-molecule solutions, addressing key challenges in R&D and manufacturing.

ChemT Biotechnology is an AI-driven company focused on transforming the biologics manufacturing industry, including the production of antibodies, proteins, and cell therapies. Their proprietary AI-driven cellular drug discovery platform optimizes biologics production, enhancing yield and efficacy. Their flagship product, Chemplify™, significantly boosts T cell yield and quality, setting a new industry benchmark for immunotherapies. With a strong team of experts from leading institutions and companies, ChemT aims to replace traditional components in biologics manufacturing with innovative small-molecule solutions, addressing key challenges in R&D and manufacturing.